In RCC, PROTAC PpD promotes the ubiquitinated degradation of P21-activated kinase-4 (PAK4), which in turn inhibits tumor proliferation and increases tumor cell death by immune cells85. The gene discussed is PAK4; the disease is renal cell carcinoma.